MBS-2612

N/A

Report date: 2024/07/24 14:56:20

Base Information

Drug NameMBS-2612
Drug Alias NameMBS-2612
ClassificationSmall molecules
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsFibrosisAutoimmune DiseasesTrauma, Nervous System
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIstesso Inc
China Registration ClassN/A

Develop Information

Active CompaniesIstesso Inc
Inactive CompaniesN/A
Active IndicationsFibrosisAutoimmune DiseasesTrauma, Nervous System
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A